Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 7(11): e49756, 2012.
Article in English | MEDLINE | ID: mdl-23152932

ABSTRACT

BACKGROUND: Bcr and Abr are GTPase activating proteins that specifically downregulate activity of the small GTPase Rac in restricted cell types in vivo. Rac1 is expressed in smooth muscle cells, a critical cell type involved in the pathogenesis of pulmonary hypertension. The molecular mechanisms that underlie hypoxia-associated pulmonary hypertension are not well-defined. METHODOLOGY/PRINCIPAL FINDINGS: Bcr and abr null mutant mice were compared to wild type controls for the development of pulmonary hypertension after exposure to hypoxia. Also, pulmonary arterial smooth muscle cells from those mice were cultured in hypoxia and examined for proliferation, p38 activation and IL-6 production. Mice lacking Bcr or Abr exposed to hypoxia developed increased right ventricular pressure, hypertrophy and pulmonary vascular remodeling. Perivascular leukocyte infiltration in the lungs was increased, and under hypoxia bcr-/- and abr-/- macrophages generated more reactive oxygen species. Consistent with a contribution of inflammation and oxidative stress in pulmonary hypertension-associated vascular damage, Bcr and Abr-deficient animals showed elevated endothelial leakage after hypoxia exposure. Hypoxia-treated pulmonary arterial smooth muscle cells from Bcr- or Abr-deficient mice also proliferated faster than those of wild type mice. Moreover, activated Rac1, phosphorylated p38 and interleukin 6 were increased in these cells in the absence of Bcr or Abr. Inhibition of Rac1 activation with Z62954982, a novel Rac inhibitor, decreased proliferation, p38 phosphorylation and IL-6 levels in pulmonary arterial smooth muscle cells exposed to hypoxia. CONCLUSIONS: Bcr and Abr play a critical role in down-regulating hypoxia-induced pulmonary hypertension by deactivating Rac1 and, through this, reducing both oxidative stress generated by leukocytes as well as p38 phosphorylation, IL-6 production and proliferation of pulmonary arterial smooth muscle cells.


Subject(s)
GTPase-Activating Proteins/deficiency , Hypertension, Pulmonary/etiology , Hypoxia/complications , Proto-Oncogene Proteins c-bcr/deficiency , Animals , Cell Proliferation , Enzyme Activation , GTPase-Activating Proteins/metabolism , Hypertension, Pulmonary/pathology , Hypertension, Pulmonary/physiopathology , Hypertrophy, Right Ventricular/pathology , Hypertrophy, Right Ventricular/physiopathology , Hypoxia/pathology , Hypoxia/physiopathology , Inflammation/pathology , Inflammation/physiopathology , Interleukin-6/metabolism , Leukocytes/pathology , Lung/blood supply , Lung/pathology , Lung/physiopathology , Mice , Models, Biological , Phosphorylation , Proto-Oncogene Proteins c-bcr/metabolism , Pulmonary Artery/pathology , Pulmonary Artery/physiopathology , Signal Transduction , p38 Mitogen-Activated Protein Kinases/metabolism , rac GTP-Binding Proteins/metabolism
2.
J Cell Sci ; 125(Pt 19): 4518-31, 2012 Oct 01.
Article in English | MEDLINE | ID: mdl-22767509

ABSTRACT

Dendritic arborization is important for neuronal development as well as the formation of neural circuits. Rac1 is a member of the Rho GTPase family that serve as regulators of neuronal development. Breakpoint cluster region protein (BCR) is a Rac1 GTPase-activating protein that is abundantly expressed in the central nervous system. Here, we show that BCR plays a key role in neuronal development. Dendritic arborization and actin polymerization were attenuated by overexpression of BCR in hippocampal neurons. Knockdown of BCR using specific shRNAs increased the dendritic arborization as well as actin polymerization. The number of dendrites in null mutant BCR(-/-) mice was considerably increased compared with that in wild-type mice. We found that the function of the BCR GTPase-activating domain could be modulated by protein tyrosine phosphatase receptor T (PTPRT), which is expressed principally in the brain. We demonstrate that tyrosine 177 of BCR was the main target of PTPRT and the BCR mutant mimicking dephosphorylation of tyrosine 177 alleviated the attenuation of dendritic arborization. Additionally the attenuated dendritic arborization found upon BCR overexpression was relieved upon co-expression of PTPRT. When PTPRT was knocked down by a specific shRNA, the dendritic arborization was significantly reduced. The activity of the BCR GTPase-activating domain was modulated by means of conversions between the intra- and inter-molecular interactions, which are finely regulated through the dephosphorylation of a specific tyrosine residue by PTPRT. We thus show conclusively that BCR is a novel substrate of PTPRT and that BCR is involved in the regulation of neuronal development via control of the BCR GTPase-activating domain function by PTPRT.


Subject(s)
Dendrites/metabolism , GTPase-Activating Proteins/metabolism , Proto-Oncogene Proteins c-bcr/metabolism , Receptor-Like Protein Tyrosine Phosphatases, Class 2/metabolism , rac1 GTP-Binding Protein/metabolism , Actins/metabolism , Amino Acid Sequence , Animals , Gene Knockdown Techniques , HEK293 Cells , Humans , Mice , Mice, Knockout , Molecular Sequence Data , Phosphorylation , Phosphotyrosine/metabolism , Polymerization , Protein Structure, Tertiary , Proto-Oncogene Proteins c-bcr/chemistry , Proto-Oncogene Proteins c-bcr/deficiency , Rats , Sequence Deletion , Signal Transduction , Substrate Specificity
3.
Mol Cell Biol ; 29(21): 5742-50, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19703997

ABSTRACT

Bcr and Abr are GTPase-activating proteins for the small GTPase Rac. Both proteins are expressed in cells of the innate immune system, including neutrophils and macrophages. The function of Bcr has been linked to the negative regulation of neutrophil reactive oxygen species (ROS) production, but the function of Abr in the innate immune system was unknown. Here, we report that mice lacking both proteins are severely affected in two models of experimental endotoxemia, including exposure to Escherichia coli lipopolysaccharide and polymicrobial sepsis, with extensive microvascular leakage, resulting in severe pulmonary edema and hemorrhage. Additionally, in vivo-activated neutrophils of abr and bcr null mutant mice produced excessive tissue-damaging myeloperoxidase (MPO), elastase, and ROS. Moreover, the secretion of the tissue metalloproteinase MMP9 by monocytes and ROS by elicited macrophages was abnormally high. In comparison, ROS production from bone marrow monocytes was not significantly different from that of controls, and the exocytosis of neutrophil secondary and tertiary granule products, including lactoferrin, was normal. These data show that Abr and Bcr normally curb very specific functions of mature tissue innate immune cells, and that each protein has distinct as well as partly overlapping functions in the downregulation of inflammatory processes.


Subject(s)
Inflammation/metabolism , Proteins/metabolism , Proto-Oncogene Proteins c-bcr/metabolism , Animals , Cytochalasin B/pharmacology , Endotoxemia/microbiology , Enzyme Activation/drug effects , Escherichia coli , GTPase-Activating Proteins , Lipopolysaccharides/pharmacology , Lung Injury/pathology , Mice , Models, Biological , Mutation/genetics , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Neutrophils/drug effects , Neutrophils/enzymology , Phagocytosis/drug effects , Proto-Oncogene Proteins c-bcr/deficiency , Reactive Oxygen Species/metabolism , rac GTP-Binding Proteins/metabolism
4.
Circ Res ; 104(1): 69-78, 2009 Jan 02.
Article in English | MEDLINE | ID: mdl-19023129

ABSTRACT

Bcr is a serine/threonine kinase activated by platelet-derived growth factor that is highly expressed in the neointima after vascular injury. Here, we demonstrate that Bcr is an important mediator of angiotensin (Ang) II and platelet-derived growth factor-mediated inflammatory responses in vascular smooth muscle cells (VSMCs). Among transcription factors that might regulate Ang II-mediated inflammatory responses we found that ligand-mediated peroxisome proliferator-activated receptor (PPAR)gamma transcriptional activity was significantly decreased by Ang II. Ang II increased Bcr expression and kinase activity. Overexpression of Bcr significantly inhibited PPARgamma activity. In contrast, knockdown of Bcr using Bcr small interfering RNA and a dominant-negative form of Bcr (DN-Bcr) reversed Ang II-mediated inhibition of PPARgamma activity significantly, suggesting the critical role of Bcr in Ang II-mediated inhibition of PPARgamma activity. Point-mutation and in vitro kinase analyses showed that PPARgamma was phosphorylated by Bcr at serine 82. Overexpression of wild-type Bcr kinase did not inhibit ligand-mediated PPARgamma1 S82A mutant transcriptional activity, indicating that Bcr regulates PPARgamma activity via S82 phosphorylation. DN-Bcr and Bcr small interfering RNA inhibited Ang II-mediated nuclear factor kappaB activation in VSMCs. DN-PPARgamma reversed DN-Bcr-mediated inhibition of nuclear factor kappaB activation, suggesting that PPARgamma is downstream from Bcr. Intimal proliferation in low-flow carotid arteries was decreased in Bcr knockout mice compared with wild-type mice, suggesting the critical role of Bcr kinase in VSMC proliferation in vivo, at least in part, via regulating PPARgamma/nuclear factor kappaB transcriptional activity.


Subject(s)
Angiotensin II/physiology , Muscle, Smooth, Vascular/drug effects , Myocytes, Smooth Muscle/drug effects , PPAR gamma/antagonists & inhibitors , Proto-Oncogene Proteins c-bcr/physiology , Angiotensin II/pharmacology , Animals , Enzyme Activation , Mice , Mice, Knockout , Muscle, Smooth, Vascular/enzymology , Myocytes, Smooth Muscle/enzymology , NF-kappa B/genetics , NF-kappa B/physiology , PPAR gamma/agonists , PPAR gamma/physiology , Phosphorylation , Phosphoserine/metabolism , Platelet-Derived Growth Factor/pharmacology , Point Mutation , Protein Processing, Post-Translational , Proto-Oncogene Proteins c-bcr/antagonists & inhibitors , Proto-Oncogene Proteins c-bcr/deficiency , Proto-Oncogene Proteins c-bcr/genetics , RNA, Small Interfering/pharmacology , Rats , Recombinant Fusion Proteins/physiology , Tunica Intima/enzymology , Tunica Intima/pathology , Vasculitis/physiopathology
5.
Mol Cell Biol ; 27(3): 899-911, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17116687

ABSTRACT

Small GTPases of the Rho family are key regulators of phagocytic leukocyte function. Abr and Bcr are homologous, multidomain proteins. Their C-terminal domain has GTPase-activating protein (GAP) activity that, in vitro, is specific for Rac and Cdc42. To address the in vivo relevance of these entire proteins, of which little is known, the current study examined the effect of the genetic ablation of Abr and Bcr in murine macrophages. The concomitant loss of Abr and Bcr induced multiple alterations of macrophage cellular behavior known to be under the control of Rac. Macrophages lacking both Abr and Bcr exhibited an atypical, elongated morphology that was reproduced by the ectopic expression of GAP domain mutant Abr and Bcr in a macrophage cell line and of constitutively active Rac in primary macrophages. A robust increase in colony-stimulating factor 1 (CSF-1)-directed motility was observed in macrophages deficient for both proteins and, in response to CSF-1 stimulation, Abr and Bcr transiently translocated to the plasma membrane. Phagocytosis of opsonized particles was also increased in macrophages lacking both proteins and correlated with sustained Rac activation. Bcr and Abr GAP mutant proteins localized around phagosomes and induced distinct phagocytic cup formation. These results identify Abr and Bcr as the only GAPs to date that specifically negatively regulate Rac function in vivo in primary macrophages.


Subject(s)
GTPase-Activating Proteins/metabolism , Macrophages/cytology , Proteins/metabolism , Proto-Oncogene Proteins c-bcr/metabolism , Sequence Homology , rac GTP-Binding Proteins/metabolism , Animals , Arginine/genetics , Asparagine/genetics , CHO Cells , Cell Membrane/drug effects , Cell Membrane/metabolism , Cell Movement/drug effects , Cricetinae , Cricetulus , Macrophage Colony-Stimulating Factor/pharmacology , Macrophages/drug effects , Mice , Mutant Proteins/metabolism , Mutation/genetics , Phagocytosis/drug effects , Phagosomes/drug effects , Protein Transport/drug effects , Proto-Oncogene Proteins c-bcr/deficiency , cdc42 GTP-Binding Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...